Lumine Group Inc. Announces Appointment of Independent
TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Lumine Group Inc. (“Lumine Group”) today announced the appointment of two
Globe Newswire7-02-2023, 21:20
Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia 5-09-2023, 17:00